scispace - formally typeset
D

David W. Piston

Researcher at Washington University in St. Louis

Publications -  248
Citations -  19927

David W. Piston is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Islet & Insulin. The author has an hindex of 66, co-authored 230 publications receiving 18364 citations. Previous affiliations of David W. Piston include Uniformed Services University of the Health Sciences & University of Washington.

Papers
More filters
Journal ArticleDOI

An improved cyan fluorescent protein variant useful for FRET.

TL;DR: Cerulean is 2.5-fold brighter than ECFP and replacement of ECFP with Cerulean substantially improves the signal-to-noise ratio of a FRET-based sensor for glucokinase activation.
Journal ArticleDOI

Use of the green fluorescent protein and its mutants in quantitative fluorescence microscopy.

TL;DR: No single GFP variant is ideal for every application, but each one offers advantages and disadvantages for quantitative imaging in living cells.
Journal ArticleDOI

Fluorescent protein FRET: the good, the bad and the ugly

TL;DR: The physical basis of FRET and the fluorescent proteins appropriate for these experiments are described and the approaches that can be used to measure FRET are reviewed, with particular emphasis on the potential artifacts associated with each approach.
Journal ArticleDOI

Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development

TL;DR: Evidence is provided that BMPs function during regional morphogenesis of the dorsal telencephalon by regulating specific gene expression, cell proliferation and local cell death.
Journal ArticleDOI

Ablation of PRDM16 and Beige Adipose Causes Metabolic Dysfunction and a Subcutaneous to Visceral Fat Switch

TL;DR: It is shown that adipocyte-specific deletion of the coregulatory protein PRDM16 caused minimal effects on classical brown fat but markedly inhibited beige adipocyte function in subcutaneous fat following cold exposure or β3-agonist treatment, indicating that PRDM 16 and beige fat cells are required for the "browning" of white fat and the healthful effects of sub cutaneous adipose tissue.